2011
DOI: 10.1128/jvi.02360-10
|View full text |Cite
|
Sign up to set email alerts
|

Rotavirus VP2 Core Shell Regions Critical for Viral Polymerase Activation

Abstract: The innermost VP2 core shell of the triple-layered, icosahedral rotavirus particle surrounds the viral genome and RNA processing enzymes, including the RNA-dependent RNA polymerase (VP1). In addition to anchoring VP1 within the core, VP2 is also an essential cofactor that triggers the polymerase to initiate double-stranded RNA (dsRNA) synthesis using packaged plus-strand RNA templates. The VP2 requirement effectively couples packaging with genome replication and ensures that VP1 makes dsRNA only within an asse… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
91
0
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
4
2
1

Relationship

2
5

Authors

Journals

citations
Cited by 62 publications
(98 citation statements)
references
References 25 publications
(59 reference statements)
6
91
0
1
Order By: Relevance
“…The AMV CP can regulate RNA synthesis by binding to the 3= ends of Alfamovirus and Ilarvirus RNAs to activate genome replication (6,23). In rotavirus, VP2 can serve as a scaffold for the viral polymerase as well as act as a cofactor for VP1 to initiate genome replication (32,38). The CPs of the plant-infecting brome mosaic virus and the bacteriophage MS2 play regulatory roles in binding to RNA elements that regulate RNA synthesis (46,50,51).…”
Section: R E T R a C T E Dmentioning
confidence: 99%
“…The AMV CP can regulate RNA synthesis by binding to the 3= ends of Alfamovirus and Ilarvirus RNAs to activate genome replication (6,23). In rotavirus, VP2 can serve as a scaffold for the viral polymerase as well as act as a cofactor for VP1 to initiate genome replication (32,38). The CPs of the plant-infecting brome mosaic virus and the bacteriophage MS2 play regulatory roles in binding to RNA elements that regulate RNA synthesis (46,50,51).…”
Section: R E T R a C T E Dmentioning
confidence: 99%
“…The BaculoDirect expression system (Life Technologies) was used in accordance with the manufacturer's protocol to create His-tagged recombinant VP1 containing the L138P lesion (rVP1 L138P ). Briefly, outward PCR and sitedirected mutagenesis were used to engineer the L138P mutation into the SA11-4F VP1 ORF of the pENTR-SA11 VP1 vector (18). The entire VP1 L138P ORF was then transferred into the BaculoDirect C-Term linear DNA by recombination with LR Clonase II.…”
Section: Methodsmentioning
confidence: 99%
“…The ORF sequences of WT or L138P mutant VP1 were cloned into the pEGFP-N1 vector (Clontech) to express the polymerases with enhanced GFP fused to their C termini (VP1 WT -GFP or VP1 L138P -GFP, respectively). The WT SA11-4F VP1 ORF was amplified from the pENTR-SA11 VP1 vector by PCR (18). Primer-generated restriction sites (5= SacI and 3= KpnI) were used to subclone the WT SA11-4F VP1 ORF into the pEGFP-N1 vector, thereby creating pEGFP-SA11-VP1 WT , which expresses VP1 WT -GFP.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations